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Catechin hydrate (CH), a strong antioxidant that scavenges radicals, is a phenolic compound that is extracted from
plants and is present in natural food and drinks, such as green tea and red wine. CH possesses anticancer poten-
tial. The mechanism of action of many anticancer drugs is based on their ability to induce apoptosis. In this study,
I sought to characterize the downstream apoptotic genes targeted by CH in MCF-7 human breast cancer cells. CH
effectively kills MCF-7 cells through induction of apoptosis. Apoptosis was confirmed by terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) and real-time PCR assays. Cells were exposed to 150 μg/ml
CH and 300 μg/mL CH for 24 hours, which resulted in 40.7% and 41.16% apoptotic cells, respectively. Moreover, a
48-hour exposure to 150 μg/ml CH and 300 μg/ml CH resulted in 43.73% and 52.95% apoptotic cells, respectively.
Interestingly, after 72 hours of exposure to both concentrations of CH, almost 100% of cells lost their integrity.
These results were further confirmed by the increased expression of caspase-3,-8, and -9 and TP53 in a time-depen-
dent and dose-dependent manner, as determined by real-time quantitative PCR. In summary, the induction of
apoptosis by CH is affected by its ability to increase the expression of pro-apoptotic genes such as caspase-3, -8,
and -9 and TP53.
Introduction
Catechin compounds including (-)- epigallocatechin-3-
gallate (EGCG), (-)- epigallocatechin (EGC), epicatechin-
3-gallate (ECG) and (p)catechin [1] have been shown to
exhibit cytostatic properties in many tumor models
[2,3]. In addition, the growth of new blood vessels
required for tumor growth has been prevented by green
tea [4]. In Asian countries, a number of epidemiological
observations have suggested that the low incidence of
some cancers is due to the consumption of green tea
[2,3]. Moreover, epidemiological observations have sug-
gested that the consumption of green tea inhibits
growth of many tumor types [5,6].
Breast cancer is the most common cancer and is the
leading cause of death for women worldwide [7]. Sev-
eral epidemiological observations have suggested that
increased consumption of green tea is related to
improved prognosis of human breast cancer [2] and
that the low risk of breast cancer is associated with
the intake of green tea in Asian-Americans [8,9].
The modulation of signal transduction pathways, inhi-
bition of cell proliferation, induction of apoptosis, inhi-
bition of tumor invasion and inhibition of angiogenesis
are mechanisms that have been established as inhibit-
ing carcinogenesis [10,11]. These potentially beneficial
effects of green tea are attributed to catechin com-
pounds, particularly EGCG, which is the most abun-
dant and extensively studied catechin compound of
green tea [12,13].
The overall medicinal effects of green tea observed
thus far, are focused on combined activities of several
compounds in green tea rather than that of a single
compound. In addition, most studies have investigated
the different synergistic bioactivities of all compounds
present in tea extracts or have been focused mainly on
t h er o l eo fE G C G .T h e r e f o r e ,t h ep r e s e n ts t u d yw a s
designed to elucidate the role of the anticancer activity
of single compound i.e. CH (Figure 1) at the molecular
level.
Materials and methods
Catechin Hydrate-A compound of Catechins
Catechin is a polyphenolic flavonoid which has been iso-
lated from a variety of natural sources including tea
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any medium, provided the original work is properly cited.leaves, grape seeds, and the wood and bark of trees such
as acacia and mahogany. Catechin is a more potent anti-
oxidant than ascorbate or a-tocopherol in certain
in vitro assays of lipid peroxidation. Catechin inhibits
the free radical-induced oxidation of isolated LDL by
AAPH [14]. Catechins and other related procyanidin
compounds have antitumor activity when tested in a
two-stage mouse epidermal carcinoma model employing
topical application. Following is the structure of
(+)-Catechin hydrate.
Preparations of CH
1 0 0m gC Hw a sd i s s o l v e di n1 0m LD M E Mm e d i u m
(10% FCS) to obtain stock solution and was further
diluted in medium to obtain desired concentrations.
Maintenance of MCF-7 Cells
The MCF-7 breast cancer cell line was a kind gift from
Dr. M. A. Akbarshah at the Mahatma Gandhi-Doeren-
kamp Center (MGDC) for Alternatives to Use of Animals
in Life Science Education, Bharathidasan University,
India. The cell line was maintained and propagated in
90% Dulbecco’s Modified Eagle’sM e d i u m( D M E M )c o n -
taining 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin. Cells were cultured as adherent mono-
layers (i.e., cultured at ~70% to 80% confluence) and
maintained at 37°C in a humidified atmosphere of 5%
CO2. Cells were harvested after being subjected to brief
trypsinization. All chemicals used were of research grade.
Viability of Cells
Cell viability was assayed using a trypan blue exclusion
test as explained earlier with slight modifications [15].
Toxicity and Cell Proliferation Assays
The Cell Titer Blue® viability assay (Promega Madison,
WI) was performed to assess the toxicity of different
concentrations of CH on MCF-7 cells. The assay was
performed according to the manufacturer’si n s t r u c t i o n s .
Briefly, MCF-7 cells (2 × 10
4 cells/well) were plated in
96-well plates and treated with 0 μg/mL CH and
160 μg/mL CH for 24 hours. Then, 40 μLo ft h eC e l l
Titer Blue solution was directly added to the wells and
incubated at 37°C for 6 hours. The fluorescence was
recorded with a 560 nm/590 nm (excitation/emission)
filter set using a Bio-Tek microplate fluorescence reader
(FLx800™), and the IC50 was calculated. Quadruplet
samples were run for each concentration of CH in three
independent experiments.
CH Treatment for a concentration- and Time-Dependent
Study
For a concentration- and time-dependent study, two sets
of CH concentrations (50 μg/mL and 150 μg/mL;
300 μg/mL and 600 μg/mL) were considered for treat-
ment of MCF-7 cells for 24 hours. I found that 50 μg/
mL CH did not show any significant induction of apop-
tosis whereas 600 μg/mL CH completely killed the cells.
Hence, 150 μg/mL and 300 μg/mL concentrations of
CH were used for further studies.
MCF-7 cells were treated with either 150 μg/mL or
300 μg/mL CH for 24, 48 and 72 hours for the terminal
deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL) assay. The cells were incubated with
t h es a m eC H c o n c e n t r a t i o n sf o r2 4a n d4 8h o u r sf o r
real-time quantitative PCR analysis.
TUNEL Assay
The DeadEnd® TUNEL assay kit (Promega, Madison,
WI) was used for studying apoptosis in a time- and
dose-dependent manner. The manufacturer’si n s t r u c -
tions were followed with slight modifications. Briefly,
MCF-7 cells (1.5 × 10
6 cells/well) were cultured in
6-well plates to study apoptosis in adherent cells. Cells
were treated with 150 μg/mL and 300 μg/mL CH for
24, 48 and 72 hours. After the incubation period, the
culture medium was aspirated off, and the cell layers
were trypsinized. The trypsinized cells were reattached
on 0.01% polylysine-coated slides, fixed with 4% metha-
nol-free formaldehyde solution, and stained according to
the DeadEnd fluorometric TUNEL system protocol [16].
The stained cells were observed using a Carl-Zeiss
(Axiovert) epifluorescence microscope using a triple
band-pass filter. To determine the percentage of cells
demonstrating apoptosis, 1000 cells were counted in
each experiment [17].
Real-time quantitative PCR analysis
The expression of apoptotic genes was analyzed by
reverse transcription-PCR (RT-PCR; Applied Biosystems
7500 Fast, Foster City, CA) using a real-time SYBR
Green/ROX gene expression assay kit (QIAgen). The
cDNA was directly prepared from cultured cells using a
Figure 1 Molecular structure of catechin hydrate.
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Page 2 of 9Fastlane® Cell cDNA kit (QIAGEN, Germany), and the
mRNA levels of Caspase 3, Caspase 8, Caspase 9 and
tp53 as well as the reference gene, GAPDH,w e r e
assayed using gene-specific SYBR Green-based Quanti-
Tect® Primer assays (QIAGEN, Germany). Quantitative
real-time RT-PCR was performed in a reaction volume
of 25 μL according to the manufacturer’s instructions.
Briefly, 12.5 μLo fm a s t e rm i x ,2 . 5μLo fp r i m e ra s s a y
(10×) and 10 μL of template cDNA (100 μg) were added
to each well. After a brief centrifugation, the PCR plate
was subjected to 35 cycles of the following conditions:
(i) PCR activation at 95°C for 5 minutes, (ii) denatura-
tion at 95°C for 5 seconds and (iii) annealing/extension
at 60°C for 10 seconds. All samples and controls were
run in triplicates on an ABI 7500 Fast Real-time PCR
system. The quantitative RT-PCR data was analyzed
by a comparative threshold (Ct) method, and the
fold inductions of samples were compared with the
untreated samples. GAPDH was used as an internal
reference gene to normalize the expression of the apop-
totic genes. The Ct cycle was used to determine the
expression level in control cells and MCF-7 cells treated
with CH for 24 and 48 h. The gene expression level was
then calculated as described earlier [18]. The results
were expressed as the ratio of reference gene to target
gene by using the following formula: ΔCt = Ct (apopto-
tic genes) - Ct (GAPDH). To determine the relative
expression levels, the following formula was used: ΔΔCt
= ΔCt (Treated) - ΔCt (Control). Thus, the expression
levels were expressed as n-fold differences relative to the
calibrator. The value was used to plot the expression of
apoptotic genes using the expression of 2
-ΔΔCt.
Results
Effect of CH on MCF-7 breast cancer cell proliferation
and apoptosis
To explore the anticancer effect of CH on MCF-7
human breast cancer cells, several in vitro experiments
were conducted.
Viability assay
The viability of cells was greater than 95%.
Determination of CH toxicity on MCF-7 cells
The cytotoxic effect of 0 μg/mL CH and 160 μg/mL CH
on MCF-7 cells was examined using the Cell Titer Blue®
v i a b i l i t ya s s a y( P r o m e g aM a d i s o n ,W I ) .Ad o s e - d e p e n -
dent reduction in color was observed after 24 hours of
treatment with CH, and 54.76% of the cells were dead
at the highest concentration of CH tested (160 μg/mL)
whereas the IC50 of CH was achieved at 127.62 μg/mL
CH (Figure 2).
Quantification of apoptosis by a TUNEL assay
To determine whether the inhibition of cell proliferation
by CH was due to the induction of apoptosis, a TUNEL
assay was used. Figures 3, 4, 5 and 6 summarize the
effect of CH on MCF-7 cells. A dose- and time-depen-
dent increase in the induction of apoptosis was observed
when MCF-7 cells were treated with CH. When com-
pared to the control cells at 24 hours, 40.7 and 41.16%
of the cells treated with 150 μg/mL and 300 μg/mL CH,
respectively, underwent apoptosis. Similarly, 43.73 and
52.95% of the cells treated with 150 μg/mL and 300 μg/
mL CH, respectively, for 48 hours underwent apoptosis.
Interestingly, after 72 hours of exposure to CH, almost
100% of the cells in both concentrations had lost their
integrity (Figure 6).
Quantification of mRNA levels of apoptotic-related genes
To investigate the molecular mechanism of CH-induced
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Figure 2 Determination of IC50 of catechin against the MCF-7














































Figure 3 Percentage of apoptotic cells in 24 hours and 48
hours incubation in blank control and treatments with
catechin hydrate (150 μg/mL and 300 μg/mL).
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Page 3 of 9apoptosis-related genes were examined. The relative
quantification of Caspase-3, -8, and -9 and Tp53 mRNA
expression levels was performed by SYBR Green-based
quantitative real-time PCR (RT-PCR) using a 7500 Fast
Real Time System (Applied Biosystems).
Figures 7 to 10 summarize the gene expression
changes of Caspase-3, -8,a n d-9 and p53. CH increased
the transcripts of Caspase 3, -8,a n d-9,a n dp53 by sev-
eral fold. The expression levels of these genes in MCF-7
cells treated with 150 μg/ml CH for 24 h increased by
5.81, 1.42, 3.29, and 2.68 fold, respectively, as compared
to the levels in untreated control cells (Figure 7). Simi-
larly, the expression levels of Caspase-3,- 8,a n d- 9 and
p53 in MCF-7 cells treated with 300 μg/ml CH for 24 h
increased by 7.09, 3.8, 478, and 4.82 fold, respectively, as
compared to levels in untreated control cells (Figure 8).
In a time-dependent manner, the expression levels of
the apoptotis-related genes in MCF-7 cells treated with
150 or 300 μg/ml CH for 48 h increased when com-
pared to the levels in untreated control cells (Figure 9
and 10). However, the expression levels of Caspase-3,
-8,a n d-9 and p53 in MCF-7 cells treated with 300 μg/
ml CH for 48 h markedly increased–40.52, 8.72, 20.26
and 10 fold–as compared to control untreated cells
(Figure 10). Together, these data suggest that these cas-
pases and p53 were induced by CH in a dose- and time-
dependent manner.
Discussion
The mechanism of action of many anticancer drugs is
based on their ability to induce apoptosis [19,20]. There
are many mechanisms through which apoptosis can be
enhanced in cells. Agents suppressing the proliferation of
malignant cells by enhancing apoptosis may constitute a
Figure 4 TUNEL assay (microscopic) after 24 hours incubation of MCF-7 against catechine treatment. A, B and C are untreated control;
D, E and F treated with 150 μg/mL of catechine; G, H and I treated with 300 μg/mL of catechine. Red fluorescence is due to Propedium Iodide
staining and observed under green filter while green fluorescence is due to FITC staining and observed under blue filter. Bright field image (B, E
and H) central row. Observations done at 200× magnification.
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vention and chemotherapy. However, unfavorable side
effects and resistance of many of the anticancer agents
that have been developed are serious problems [21].
Thus, there is a growing interest in the use of plant-
based compounds to develop safe and more effective
therapeutic agents for cancer treatment [22]. Because the
side effects of green tea are modest and well tolerated
[23], increasing attention is being given to the application
of tea catechins for cancer prevention and treatment.
EGCG conjugated with capric acid has been shown to be
the catechin that most potently induces apoptosis in
U937 cells. C10 has been shown to enhance apoptosis in
human colon cancer (HCT116) cells [24]. Catechin com-
pounds have been shown to exhibit cytostatic properties
in many tumor models [2,3]. Babich et al. (2005) found
that catechin and epicatechin (EC) are less toxic than
other catechin compounds, including ECG, CG, EGCG
and EGC, in HSC-2 carcinoma cells and HGF-2 fibro-
blasts [25]. Hence, I was interested in identifying whether
apoptosis was the mode of death for cancer cells treated
with CH (the least toxic form). To do so, I sought to
determine the role of CH in inhibiting cell growth and
modulating the expression of caspases-3, -8, and -9
and p53.
The data presented in this paper demonstrate a time-
and dose-dependent inhibition by CH of MCF-7 human
breast cancer cell proliferation. There are many mechan-
isms through which apoptosis can be induced in cells.
The sensitivity of cells to any of these stimuli may vary
depending on factors such as the expression of pro- and
anti-apoptotic proteins. The mitochondrial apoptotic
pathways and death receptor pathways are the two major
pathways that have been characterized in mammalian
Figure 5 TUNEL assay (microscopic) after 48 hours incubation of MCF-7 against catechine treatment. A, B and C are untreated control;
D, E and F treated with 150 μg/mL of catechine; G, H and I treated with 300 μg/mL of catechine. Red fluorescence is due to Propedium Iodide
staining and observed under green filter while green fluorescence is due to FITC staining and observed under blue filter. Bright field image (B, E
and H) central row. Observations done at 200× magnification.
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Page 5 of 9cells. The mitochondria have a central role in regulating
the caspase cascade and apoptosis [26]. Caspases have a
central role in the apoptotic process in that they trigger a
cascade of apoptotic pathways [27]. The release of cyto-
chrome -c from mitochondria leads to the activation of
procaspase-9 and then caspase-3 [26]. The activation of
caspase-3 is an important downstream step in the apop-
totic pathway [28]. In addition, the effector caspase, cas-
pase-3, and the initiator caspases, caspase-8 and -9, are
the main executors of apoptosis [29]. Caspase-8 is in the
death receptor pathway whereas caspase-9 is in the mito-
chondrial pathway, and both pathways share caspase-3
[30]. Treatment with EGCG conjugated with capric acid
increases the formation of reactive oxygen species (ROS),
loss of mitochondrial membrane potential (MMP),
release of cytochrome c, activation of caspase-9 and acti-
vation of caspase-3. In addition, EGCG conjugated with
capric acid also activates the extrinsic pathway as demon-
strated by the time-dependent increase in Fas expression
and caspase-8 activity [24]. Two distinct downstream
pathways have been identified for activation of apoptosis
after caspase-8 is activated. In one pathway, caspase-8
directly processes downstream effector caspase-3, -6, and
-7. In an alternative pathway, caspase-8 activates cross-
talk between the death receptor pathway and the mito-
chondrial pathway by the cleavage of Bid to Bid, a
pro-apoptotic member of the Bcl2 family. The activation
of caspase-8 has a central role in Fas-mediated apoptosis.
Moreover, the cleavage of Bid has been shown to be asso-
ciated with caspase-8 activation [31]. Taken together, the
data presented in this study suggest that catechin-
induced apoptosis is mediated by the death receptor and
mitochondrial apoptotic pathways as demonstrated by
increased expression levels of caspase-3, -8 and -9 after
Figure 6 TUNEL assay (microscopic) after 72 hours incubation of MCF-7 against catechine treatment. A, B and C are untreated control;
D, E and F treated with 150 μg/mL of catechine; G, H and I treated with 300 μg/mL of catechine. Red fluorescence is due to Propedium Iodide
staining and observed under green filter while green fluorescence is due to FITC staining and observed under blue filter. Bright field image (B, E
and H) central row. Observations done at 200× magnification.
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Expression of apoptosis related genes after 24 hr 
exposure of catechin hydrate (150 μg/mL) 
Figure 7 Comparision of chang in expression of apoptosis
related genes as fold change (ratio of target:reference gene) in








































































Expression of apoptosis related genes after 24 hr 
exposure of catechin hydrate (300 μg/mL) 
Figure 8 Comparision of chang in expression of apoptosis
related genes as fold change (ratio of target:reference gene) in









































































Expression of apoptosis related genes after 48 hr 
exposure of catechin hydrate (150 μg/mL) 
Figure 9 Comparision of chang in expression of apoptosis
related genes as fold change (ratio of target:reference gene) in










































































Expression of apoptosis related genes after 48 hr 
exposure of catechin hydrate (300 μg/mL) 
Figure 10 Comparision of chang in expression of apoptosis
related genes as fold change (ratio of target:reference gene) in
MCF-7 cells after 48 hours of exposure of 300 μg/mL of
catechin.
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Page 7 of 9CH treatment. In addition, this study suggests that cate-
chin activates the extrinsic death pathway as demon-
strated by increased expression levels of caspase-8.
p53, the most commonly mutated gene associated with
cancer [32], helps to regulate the cell cycle and has a key
role in ensuring that damaged cells are destroyed by apop-
t o s i s .T h ed a t ap r e s e n t e di nt h i ss t u d yi n d i c a t et h a tt h e
expression levels of p53 and caspase-3, -8 and -9 were
markedly increased after CH treatment in a concentra-
tion-dependent manner. These data suggest that catechin
induced apoptosis by regulating pro-apoptotic genes.
The possibility that p53-mediated apoptosis may be
associated with the activation of caspase-3, -8 and -9 is
suggested by the ability of p53 to activate both the
extrinsic and intrinsic apoptotic pathways [30,33,34].
p53 enhances cancer cell apoptosis, and it prevents cell
replication by stopping the cell cycle at G1 or interphase
[35]. By inducing the release of mitochondrial cyto-
chrome c, p53 might be able to activate effector cas-
pases including caspase-3. Caspase-3, -8, and -9 may be
the apoptotic effector machinery engaged by p53 to
mediate teratogen-induced apoptotic pathways [36].
Conclusion
In conclusion, to our knowledge, the results presented
in this study show for the first time that CH exhibits
anticancer effects by blocking the proliferation of MCF7
cells and inducing apoptosis in part by modulating
expression levels of caspase-3, -8, and -9 and p53. The
induction of apoptosis by CH is affected by its ability to
regulate the expression of pro-apoptotic genes such as
caspase-3, -8, and -9 and p53. Taken together, it is most
likely that CH induced, at least in part, p53 and cas-
pase-mediated apoptosis in MCF-7 cells. Therefore, the
present study demonstrates that CH significantly inhi-
bits the growth of MCF-7 human breast cancer cells in
vitro, and it provides the underlying mechanism for the
anticancer activity. CH suppressed the growth of breast
cancer cells without significant toxicity, making it a
promising chemotherapeutic agent for breast cancer
treatment; this is likely to be confirmed by further
investigation.
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